Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., discusses cannabinoid-based drug pipeline.

October 17, 2018 admin CEO Interview, Healthcare Comments Off on Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., discusses cannabinoid-based drug pipeline.

 

 

 

 

 

 

 

 

Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., shares update on Tetra's Cannabinoid-based drug pipeline as opioid alternative.

Investor Presentation Deck

This content is available to members only.

If you are an existing member, please LOGIN

Note a member? Sign up for a FREE trial account ($195 per month value), and get immediate access. Free offer expires June 15, 2019.

Register New Account

Free Membership

.

Institutional / team access subscriptions, contact Melissa Walters 212-871-2057 ext 2
subscribe@wallstreetreporter.com.




Related Articles

Healthcare

FDA Grants Rolling Review for CytoDyn’s (OTC: CYDY) Planned BLA for Investigational HIV Therapy Leronlimab (PRO 140)

March 7, 2019 admin Healthcare, Newsmakers Comments Off on FDA Grants Rolling Review for CytoDyn’s (OTC: CYDY) Planned BLA for Investigational HIV Therapy Leronlimab (PRO 140)

VANCOUVER, Washington, March 04, 2019 — CytoDyn Inc. (otc.qb:CYDY), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, today announced that the FDA has reviewed […]

Add to my social media sites
SubscribeDiggdel.icio.usFacebookRedditStumbleUponTechnorati
Healthcare

CytoDyn (OTC: CYDY) Submits 510(k) Pre-Submission Application to U.S. FDA for ProstaGene(TM) Prognostic Test

June 20, 2019 admin Healthcare, Newsmakers Comments Off on CytoDyn (OTC: CYDY) Submits 510(k) Pre-Submission Application to U.S. FDA for ProstaGene(TM) Prognostic Test

Dr. Richard Pestell, who leads CytoDyn’s cancer, NASH and GvHD programs, recently named to The Order of Australia, established by Queen Elizabeth II VANCOUVER, Washington, June 19, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the […]

Add to my social media sites
SubscribeDiggdel.icio.usFacebookRedditStumbleUponTechnorati
Newsmakers

American Premium Water Corp. (OTC: HIPH) CEO Provides Update to Shareholders on Q1 and Outlook for Remainder of 2019

May 10, 2019 admin Newsmakers Comments Off on American Premium Water Corp. (OTC: HIPH) CEO Provides Update to Shareholders on Q1 and Outlook for Remainder of 2019

PLAYA VISTA, May 09, 2019 – American Premium Water Corporation (OTC: HIPH) CEO Ryan Fishoff provides an update to shareholders on the Company’s progress in the 1 quarter and outlook for the rest of the year. […]

Add to my social media sites
SubscribeDiggdel.icio.usFacebookRedditStumbleUponTechnorati